Article ; Online: Extracellular matrix derived from Wharton's Jelly-derived mesenchymal stem cells promotes angiogenesis via integrin αVβ3/c-Myc/P300/VEGF.
2022 Volume 13, Issue 1, Page(s) 327
Abstract: Background: Angiogenesis is required in many physiological conditions, including bone regeneration, wound healing, and tissue regeneration. Mesenchymal stem cells-derived extracellular matrix (MSCs-ECM) could guide intricate cellular and tissue ... ...
Abstract | Background: Angiogenesis is required in many physiological conditions, including bone regeneration, wound healing, and tissue regeneration. Mesenchymal stem cells-derived extracellular matrix (MSCs-ECM) could guide intricate cellular and tissue processes such as homeostasis, healing and regeneration. Methods: The purpose of this study is to explore the effect and mechanism of ECM derived from decellularized Wharton's Jelly-derived mesenchymal stem cells (WJ-MSCs) on endothelial cell viability and angiogenesis. The human umbilical vein endothelial cells (HUVECs) were pretreated with WJ-MSCs ECM for 2d/7d/14d, respectively. After pretreatment, the angiogenesis ability of HUVECs was detected. Results: In this study, we found for the first time that WJ-MSCs ECM could improve the angiogenesis ability of HUVECs with a time-dependent manner in vitro. Mechanically, WJ-MSCs ECM activated the focal adhesion kinase (FAK)/P38 signaling pathway via integrin αVβ3, which further promoted the expression of the cellular (c)-Myc. Further, c-Myc increased histone acetylation levels of the vascular endothelial growth factor (VEGF) promoter by recruiting P300, which ultimately promoting VEGF expression. Conclusions: ECM derived from Wharton's Jelly-derived mesenchymal stem cells promotes angiogenesis via integrin αVβ3/c-Myc/P300/VEGF. This study is expected to provide a new approach to promote angiogenesis in bone and tissue regeneration. |
---|---|
MeSH term(s) | Cell Differentiation ; Cell Proliferation ; Cells, Cultured ; E1A-Associated p300 Protein/metabolism ; Extracellular Matrix/metabolism ; Human Umbilical Vein Endothelial Cells/cytology ; Human Umbilical Vein Endothelial Cells/metabolism ; Humans ; Integrin alphaVbeta3/metabolism ; Mesenchymal Stem Cells/cytology ; Mesenchymal Stem Cells/metabolism ; Neovascularization, Physiologic ; Proto-Oncogene Proteins c-myc/metabolism ; Vascular Endothelial Growth Factor A/metabolism ; Wharton Jelly/cytology ; Wharton Jelly/metabolism |
Chemical Substances | Integrin alphaVbeta3 ; MYC protein, human ; Proto-Oncogene Proteins c-myc ; VEGFA protein, human ; Vascular Endothelial Growth Factor A ; E1A-Associated p300 Protein (EC 2.3.1.48) ; EP300 protein, human (EC 2.3.1.48) |
Language | English |
Publishing date | 2022-07-18 |
Publishing country | England |
Document type | Journal Article |
ZDB-ID | 2548671-8 |
ISSN | 1757-6512 ; 1757-6512 |
ISSN (online) | 1757-6512 |
ISSN | 1757-6512 |
DOI | 10.1186/s13287-022-03009-5 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.